Tijerino A et al. |
Overexpression of the Trichoderma brevicompactum tri5 gene: effect on the expression of the trichodermin biosynthetic genes and on tomato seedlings. |
2011 |
Toxins (Basel) |
pmid:22069764
|
Chang PK et al. |
Cyclopiazonic acid biosynthesis of Aspergillus flavus and Aspergillus oryzae. |
2009 |
Toxins (Basel) |
pmid:22069533
|
Duke SO and Dayan FE |
Modes of action of microbially-produced phytotoxins. |
2011 |
Toxins (Basel) |
pmid:22069756
|
Luebker DJ et al. |
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. |
2005 |
Toxicology |
pmid:16129535
|
Fuhrmeister J et al. |
Prooxidative toxicity and selenoprotein suppression by cerivastatin in muscle cells. |
2012 |
Toxicol. Lett. |
pmid:23092657
|
Nishimoto T et al. |
Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs. |
2007 |
Toxicol. Appl. Pharmacol. |
pmid:17599378
|
Flint OP et al. |
Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. |
1997 |
Toxicol. Appl. Pharmacol. |
pmid:9221828
|
Masters BA et al. |
In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes. |
1995 |
Toxicol. Appl. Pharmacol. |
pmid:7878672
|
Kocarek TA et al. |
Regulation of phenobarbital-inducible cytochrome P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes. |
1993 |
Toxicol. Appl. Pharmacol. |
pmid:8511800
|
Flint OP et al. |
HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture. |
1997 |
Toxicol. Appl. Pharmacol. |
pmid:9221829
|